Genomics of Drug Sensitivity in Cancer MG-132
Synonyms LLL cpd, MG 132, MG132
Targets Proteasome, CAPN1
Target pathway Protein stability and degradation
PubCHEM ID 462382
Jsmol
Download molecule 462382
PUBCHEM IUPAC INCHI InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1
Smiles O=C(OCC1(=CC=CC=C1))NC(C(=O)NC(C(=O)NC(C=O)CC(C)C)CC(C)C)CC(C)C
Cluster number 128
calculated LogS -4,865
Molecular weight 475,628
calculated LogP 3,1698
H-Acceptors 8
H-Donors 3
Ro5 violations 0
Druglikeness -14,824
DrugScore 0,280651912900666
Mutagenic none
Tumorigenic none
Reproductive Effective none
Irritant none
Fish Toxicity High FHMT
Fish Toxicity2 1,2513
Rat Acute Toxicity 2,2064
Acute Oral Toxicity III
Caco-2 Permeability Caco2-
Caco-2 Permeability2 0,8851
P-glycoprotein Substrate Substrate
P-glycoprotein Inhibitor Non-inhibitor
P-glycoprotein Inhibitor2 Non-inhibitor
Human Ether-a-go-go-Related Gene Inhibition Weak inhibitor
Human Ether-a-go-go-Related Gene Inhibition2 Non-inhibitor
Tetrahymena Pyriformis Toxicity High TPT
Tetrahymena Pyriformis Toxicity2 0,172
AMES Toxicity Non AMES toxic
CYP450 2C9 Substrate Non-substrate
CYP450 3A4 Substrate Non-substrate
CYP450 3A4 Inhibitor Inhibitor
CYP450 2C19 Inhibitor Inhibitor
CYP450 2C9 Inhibitor Non-inhibitor
CYP450 2D6 Inhibitor Non-inhibitor
CYP450 1A2 Inhibitor Non-inhibitor
CYP450 2D6 Substrate Non-substrate
Biodegradation Not ready biodegradable
Carcinogenicity (Three-class) Non-carcinogens
Carcinogens Non-required
Blood-Brain Barrier BBB+
CYP Inhibitory Promiscuity Low CYP Inhibitory Promiscuity
Honey Bee Toxicity Low HBT
Renal Organic Cation Transporter Non-inhibitor
Subcellular localization Mitochondria
Human Intestinal Absorption HIA+
Aqueous solubility -3,1112
Information useful only for research purposes.